-
Professor Micha Srour: Advances and Challenges of CAR-T Therapy in CLL | 2025 Conference on Cellular Therapy and Biomedical Frontiers
Editor’s Note: Cellular therapy has emerged as a breakthrough treatment modality, showing remarkable efficacy across various hematologic malignancies. However, its application in chronic lymphocytic leukemia (CLL) continues to face notable…
-
Professor Stefan O. Ciurea: Adoptive Cellular Therapy After Hematopoietic Stem Cell Transplantation
2025 International Conference on Cell Therapy and Biomedical Frontiers Editor’s Note: On October 31, 2025, the International Conference on Cell Therapy and Biomedical Frontiers was successfully held in Xiong’an, Hebei…
-
Prof. Huang Xiaojun: Decoding Homeostatic Remodeling in Haploidentical Hematopoietic Stem Cell Transplantation—From HLA Mismatch to Immune Rebalancing
2025 International Conference on Cell Therapy and Biomedical Frontiers Editor’s Note: On October 31, 2025, the International Conference on Cell Therapy and Biomedical Frontiers was grandly held in Xiong’an, Hebei…
-
FACO China–Japan Expert Dialogue | Professors Jin Li, Xiaotian Zhang, and Koji Kono Discuss Precision Treatment Advances in HER2-Positive Gastric Cancer
China, Japan, and other Asian countries have some of the highest rates of gastric cancer worldwide. In China, the majority of patients are still diagnosed at an advanced stage, having already lost the opportunity for curative surgery. Effective systemic therapy is therefore essential for improving survival. In recent years, innovative drugs represented by antibody–drug conjugates…
-
Highlights from the 13th International Conference of the Federation of Asian Clinical Oncology (FACO 2025)
At the recent FACO 2025 Conference held in Shanghai, Dr. Joon Oh Park, President of KSMO and President-elect of FACO, shared his perspectives on the evolving landscape of cancer treatment…
Connecting Medical Expertise through Media
